Novant Health Clinical Research provides access to a variety of infectious disease research studies.
Four trials are currently active for this specific category
Category: Infectious Disease
||A Randomized, Multicenter, Single Blinded, Parallel Study of the Safety of 100mg and 200mg Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged ≥ 13 Years
||A Prospective, Multicenter, Randomized, Evaluator-Blinded, Comparator-Controlled Study to Describe the Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin Structure Infections (cSSSI) and Staphylococcus Aureus Bacteremia Among Subjects with Moderate or Severe Renal Impairment
||A Phase III, randomized, double-blind, double-dummy study to compare the efficacy and safety of Dalbavancin to a comparator (vancomycin and linezolid) for the treatment of acute bacterial skin and skin structure infections
||A Phase II randomized, double-blind, placebo controlled, dose-ranging study to assess the safety and efficacy of VP20621for the prevention of recurrence of clostridium difficile infection (CDI) in adults previously treated for CDI